European Pharmaceutical Review

AUGUST 9, 2022

After a prolonged period of scepticism towards major moves in the mergers and acquisitions (M&A) market, leading biopharmaceutical multinationals are returning to big deal-making. Big Pharma accounted for about 77 percent of M&A spending in the biopharma sector in the second quarter.

Pharma 69

Pharma Biopharma Leads Specialization 69

Pharmaceutical Technology

MAY 24, 2023

This major difference leads to very different requirements and processes for the clinical trial supply chain, which are summarized below. CGT have highly unique and specialized manufacturing processes. Taken together, this all leads to eye-popping costs for the drug sponsor and of course for the patient and relevant insurance provider.

Manufacturing 98

Manufacturing Transportation Specialization Patients 98

pharmaphorum

OCTOBER 18, 2022

Oculis SA, a global biopharmaceutical company that develops treatments for saving sight and improving eye care with breakthrough innovations, is to combine with the European Biotech Acquisition Corp (EBAC), a special purpose acquisition company (SPAC) that has screened over 100 European biotechnology companies.

Biopharma 59

Biopharma Management Specialization Physicians 59

PM360

JUNE 16, 2023

In many cases, the biotech companies leading the commercialization in the U.S. the Institute for Clinical and Economic Review (ICER) is playing a lead role in the initiative to get the value equation right for emerging rare disease products. rebates, paybacks, or earned payments) (Figure 1). In the U.S., Pang notes that in the U.S., “one

Marketing 98

Marketing Management Insurance Specialization 98

pharmaphorum

SEPTEMBER 30, 2022

The deal – which includes additional milestones of up to $633 million plus tiered royalties on sales and R&D funding – focuses on VENT-01, the lead drug in Ventus’ peripherally-restricted NLRP3 inhibitor programme, which is currently in preclinical development.

Biopharma 59

Biopharma Specialization Sales Leads 59

Medgadget

MARCH 2, 2023

This leads to substantial damage to healthy tissues and too often results in poor outcomes. Special software that takes DICOM images from CT scanners and creates a treatment plan, defines the distribution of the Alpha DaRT sources within the tumor. which are currently recruiting patients.

Manufacturing 82

Manufacturing Leads Patients Medicine 82

PM360

SEPTEMBER 15, 2022

Quantitative survey results can often lead to a false sense of security around pre-selected response options, therefore missing critical contextual information that helps someone truly understand the patient’s perspective. This sub-set of office personnel is valuable and often leads to rich insights if marketers can spend the time/money.

Patients 98

Patients Healthcare Healthcare Marketing 98

The Marketing Advantage

APRIL 6, 2021

April 6, 2021 The biopharma industry rightfully places a great deal of emphasis on the importance of having a sales compensation plan that pays for performance. In order to truly pay for performance, a biopharma sales compensation plan must be designed such that it meets the following two attributes: Pay-for-Performance Attributes.

Sales 52

Sales Biopharma Marketing Specialization 52

European Pharmaceutical Review

DECEMBER 21, 2022

Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure. During his time at Genentech Stefan has advanced several small molecules and new modalities (antibody‑drug conjugates, oligonucleotides and peptides) into the clinic as lead chemist and technical development leader.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

The Marketing Advantage

MAY 8, 2023

This, in turn, calls for a more expert and specialized sales force. This calls for a more specialized and expert sales force, requiring longer and more rigorous hiring and training processes. Thus, one role of a rare disease sales force is education on the rare disease and its diagnosis.

Sales 52

Sales Physicians Consulting Education 52

Pharma Marketing Network

JANUARY 12, 2023

In three short years, Kite has grown to be the largest CAR T-cell therapy company in the world, with an extensive in-house manufacturing network devoted to creating this specialized treatment for patients. These experiences have empowered Christi to become a leading industry voice advocating fiercely for patients.

Healthcare 52

Healthcare Healthcare Networking Manufacturing 52

Clarivate

AUGUST 7, 2023

The integration with Dialog has further strengthened Clarivate as a leading global provider of information and insights that can accelerate the innovation cycle, bolstering a robust, integrated platform of life science intelligence solutions that support the entire drug development lifecycle.

Specialization 52

Specialization Management Healthcare Healthcare 52

Pharmaceutical Technology

JANUARY 25, 2023

Although expert opinions differ on the future of special purpose acquisition companies (SPACs), some companies are continuing to explore their use. In December 2022, AEON Biopharma, a biopharmaceutical company, announced its plans to go public through a merger with the SPAC Priveterra Acquisition Corp.

Marketing 69

Marketing Biopharma Pharma Competition 69

Clarivate

DECEMBER 6, 2022

The confluence of highly specialized oncology care and new locations in Wisconsin’s primary and secondary markets has expanded Froedtert’s reach and reputation—which will be critical as local rival Advocate Aurora prepares to merge with North Carolina-based Atrium Health. Bill Melville, Lead Healthcare Research Analyst.

Networking 52

Networking Healthcare Healthcare Competition 52

PM360

AUGUST 7, 2024

Ari Wexler Group Senior Vice President, Engagement Strategy CMI Media Group awexler@cmimediagroup.com Historically, the pharmaceutical marketing industry has relied on leading performance KPIs, such as likes, shares, and clicks to measure a campaign’s success against brand goals.

Media 52

Media Education Physicians Marketing 52

Pharmaceutical Technology

MARCH 20, 2023

One of the many segments where sub-Saharan Africa could lead the world in clinical trials is therapies for sickle cell diseases, which disproportionately impacts Black people in far higher numbers than other racial groups. Yet in the period analysed, GlobalData recorded just 24 clinical trials for sickle cell diseases in the region.

Distribution 52

Distribution Management Patients Transportation 52

PM360

JUNE 11, 2022

To help pharma to form better working relationships with patients, we asked patients who have experience working with the industry, pharma marketers who have partnered with patients, and agencies and other companies who specialize in patient engagement to tell us: What do you look for in a partnership with a pharma company/patient?

Patients 59

Patients Pharma Education Media 59

PM360

OCTOBER 3, 2023

Diversity/Multicultural: Anna Czene, Vice President, Corporate Communications & DEI Lead, CareDx, Inc. Men’s Health: Nuvan Augustin Dassanaike, Senior Vice President Digital and Marketing Strategy & Operations, Accord BioPharma Nephrology/Urology: W. Braun Medical, Inc.

Education 122

Education Marketing Media Pharmaceutical 122

European Pharmaceutical Review

JANUARY 9, 2023

In the first 11 months of 2022, biopharma M&A value dropped by 42 percent compared to 2021, with Pfizer’s acquisition of Biohaven , the single largest deal up to December 2022. Alliances were a significant focus for biopharma and companies’ M&A strategies in 2022. Biopharma alone held over $1.4

Biopharma 98

Biopharma Specialization Leads Competition 98

PM360

AUGUST 24, 2023

PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. Braun Medical, Inc.

Marketing 52

Marketing Pharmaceutical Healthcare Healthcare 52

PM360

OCTOBER 5, 2023

In total, PM360 , a leading life sciences marketing industry trade publication, recognized 73 winners across eight overall categories: Companies of the Year, CEOs of the Year, Products of the Year, Marketer of the Year, Marketing Team of the Year, Lifetime Achievement, Brand Champions, and Initiatives. Braun Medical, Inc.

Marketing 52

Marketing Education Pharmaceutical Media 52

Pharmaceutical Technology

APRIL 24, 2023

The rise of biologics In the lead-up to the 2020 boom, Swiss drugmaker Roche spent some $11 billion on biotechnology research and development in 2018. Because biologics work with live cells, manufacturing them is difficult, and highly specialized facilities and infrastructure are needed. Biopharma outsourcing has rapidly developed.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52

pharmaphorum

JULY 27, 2022

Demerging Haleon has allowed GSK to focus on higher-margin prescription medicines and vaccines, as well as provide cash for investment in its biopharma pipeline. GSK has already made moves in this direction this year with deals to buy cancer specialist Sierra Oncology for $1.9 billion and vaccine firm Affinivax for up to $3.3

Sales 52

Sales Biopharma Medicine Prescription 52

Pharmaceutical Technology

AUGUST 26, 2008

“The inherent advantages of biopharma are that it allows you to pursue therapies against targets that are not small molecule therapies, for example by targeting protein-protein interactions and targeting GPCRs (G-protein coupled receptors),” he says. “Biotechnology has exploded across the industry. .

Pharmaceutical 40

Pharmaceutical Manufacturing Biopharma Medicine 40